Bioventus (NasdaqGS:BVS) FY Conference Transcript

Bioventus (NasdaqGS:BVS) FY Conference January 14, 2026 12:45 PM ET Company ParticipantsMark Singleton - SVP and CFO \Robert Claypoole - CEOConference Call ParticipantsNone - AnalystNoneGood morning, everyone. Welcome, thank you for joining us. My name is David Brumund. I'm an associate on the healthcare team at J.P. Morgan, and today I have the pleasure of introducing the Bioventus team. Joining us today is CEO Rob Claypoole and CFO Mark Singleton. Just a quick reminder on format: this will be a 20-minute ...